Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

15 Nov 2010 07:00

RNS Number : 1376W
Persimmon PLC
15 November 2010
 

 

 

INTERIM MANAGEMENT STATEMENT

 

MONDAY 15 NOVEMBER 2010

 

 

 

Persimmon plc today releases its Interim Management Statement which covers the period from 1 July 2010 to 15 November 2010 and confirms current trading in line with expectations.

 

Since 1 July 2010, sales volumes have remained stable with sales prices and margins holding firm. Although weekly sales increased gradually during September, we did not experience the normal autumn increase in visitor levels and reservations. Cancellation rates remain at a low level of c. 19%.

 

As previously stated at the time of our Half Year Results announcement, we anticipate increasing our sales revenues by c. 10% this year. We expect to legally complete c. 9,400 homes for the year ending 31 December 2010 (2009: 8,976), an increase of c. 5%. We have continued to generate good levels of free cash and now expect that total borrowings at the year end will be lower than £80 million, well ahead of previous guidance.

 

Consistent with our stated strategy of focusing on improving margins, we expect to increase underlying operating margin for the full year to c. 8% (2009: 4%).

 

Mortgage availability remains a major obstacle for customers who wish to purchase a home, especially first time buyers who do not have the required large deposits. Further recovery in industry output and sales will be dependent upon an increase in the supply of mortgage products on appropriate terms.

 

However, we are fully sold up for the current year and we are in a strong financial position with over £460 million of sales already reserved beyond 2010 (2009: £500 million). Our new site starts are proceeding as planned with 60 new sites opened so far through the second half with another 15 to come through by the end of November. This will maintain the strength of our sales network at c. 380 active sites into the New Year. The outlook for sales and volumes for the full year of 2011 is as usual dependent upon the forthcoming spring selling season.

 

We have remained selective in our land replacement since the half year and have acquired c. 4,000 new plots on 41 sites so far in the second half, including c. 20% of plots from our strategic landbank. These investments continue to be made at good margins and will offer excellent returns to the business over the medium term. We also continue to improve the quality of our existing landbank in support of the delivery of improving underlying operating margins.

 

In summary, we expect our performance for 2010 to demonstrate the progress we have made in pursuing our strategy of operating margin improvement and growth in operating cash generation. With the strength of our balance sheet and high quality land holdings we will continue to successfully develop our business in these challenging markets.

 

We will give a further update on progress and trading following the year end on Monday 10 January 2011.

 

For further information, please contact:

 

Edward Orlebar

Charlotte McMullen

Marylène Guernier

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

M:Communications

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7920 2369

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUUABRRWAAAAA
Date   Source Headline
2nd Jul 201810:36 amRNSTotal Voting Rights
28th Jun 201810:53 amRNSDirectorate Change
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
1st Jun 20184:10 pmRNSTotal Voting Rights
1st Jun 20181:43 pmRNSBlock listing Interim Review
1st May 20183:08 pmRNSTotal Voting Rights
25th Apr 20184:21 pmRNSResult of AGM
25th Apr 20187:00 amRNSTrading Update
17th Apr 20188:30 amRNSCapital Markets Event
13th Apr 201810:45 amRNSDirector/PDMR Shareholding
9th Apr 20189:49 amRNSExtension of Bank Facilities
3rd Apr 20184:30 pmRNSTotal Voting Rights
3rd Apr 20184:30 pmRNSDirector/PDMR Shareholding
29th Mar 20181:32 pmRNSDirector/PDMR Shareholding
19th Mar 201811:59 amRNSAnnual Financial Report
15th Mar 20184:35 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAppointment of Chairman
8th Mar 20183:53 pmRNSDirector/PDMR Shareholding
2nd Mar 20184:05 pmRNSDirector/PDMR Shareholding
1st Mar 20186:10 pmRNSTotal Voting Rights
28th Feb 20185:31 pmRNSEBT Share Purchase
27th Feb 20187:00 amRNSBoard Changes
27th Feb 20187:00 amRNSFinal Results
23rd Feb 20187:00 amRNSReduction of 2012 LTIP Awards
1st Feb 201812:20 pmRNSTotal Voting Rights
9th Jan 20187:00 amRNSTrading Update
2nd Jan 201811:17 amRNSTotal Voting Rights
21st Dec 20175:08 pmRNSDirector/PDMR Shareholding
20th Dec 20175:31 pmRNSDirector/PDMR Shareholding
15th Dec 20177:00 amRNSBoard Changes
11th Dec 20175:06 pmRNSDirector/PDMR Shareholding
1st Dec 20175:01 pmRNSDirector/PDMR Shareholding
1st Dec 20174:58 pmRNSBlock listing Interim Review
1st Dec 20174:55 pmRNSTotal Voting Rights
20th Nov 20179:55 amRNSHolding(s) in Company
8th Nov 20177:00 amRNSTrading Statement
6th Nov 20179:38 amRNSAdditional Listing
1st Nov 20174:51 pmRNSTotal Voting Rights
31st Oct 20172:39 pmRNSHolding(s) in Company
23rd Oct 20173:43 pmRNSDirector/PDMR Shareholding
16th Oct 20174:32 pmRNSHolding(s) in Company - Replacement
16th Oct 201711:45 amRNSHolding(s) in Company
11th Oct 20173:25 pmRNSHolding(s) in Company
5th Oct 20174:22 pmRNSHolding(s) in Company
2nd Oct 20175:01 pmRNSTotal Voting Rights
1st Sep 20174:18 pmRNSTotal Voting Rights
1st Sep 20179:00 amRNSAdditional Listing
22nd Aug 20177:00 amRNSHalf Year Results
5th Jul 20177:00 amRNSTrading Update
27th Jun 20175:40 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.